Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging

Journal of Computer Assisted Tomography

Volumn 32, Issue 2, 2008, Pages 313-319

  Furutani, Kaori ^a,b   Harada, Masafumi ^a   Mawlan, Mahmut ^a   Nishitani, Hiromu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

FSPGR; MRI; Spin echo

Indexed keywords

IMAGE ENHANCEMENT; MAGNETISM; PATHOLOGY; RESONANCE; SPIN POLARIZATION;

3-DIMENSIONAL; BRAIN METASTASIS; CONDITION; FSPGR; SIGNAL INTENSITIES; SLICE THICKNESS; SMALL LESIONS; SPIN ECHO; STEADY STATE; T1-WEIGHTED;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; GADOTERIDOL;

3 DIMENSIONAL FAST SPOILED GRADIENT RECALLED ACQUISITION; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SPIN ECHO; STEADY STATE; THREE DIMENSIONAL IMAGING; TUMOR LOCALIZATION;

EID: 41749092576     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318074fd9d     Document Type: Article

References (21)

1. Trattnig S, Ba-Ssalamah A, Noebauer-Huhmann IM, et al. MR contrast agent at high-field MRI (3 Tesla). Top Magn Reson Imaging. 2003;14:365-375.
2. Engh JA, Flickinger JC, Niranjan A, et al. Optimizing intracranial metastasis detection for stereotactic radiosurgery. Stereotact Funct Neurosurg. 2007;86:162-168.
3. Rand S, Maravilla KR. Uses and limitations of spoiled gradient-refocused imaging in the evaluation of suspected intracranial tumors. Top Magn Reson Imaging. 1992;4:7-16.
4. Cherryman G, Golfieri R. Comparison of spin echo T1-weighted and FLASH 90 degrees gadolinium-enhanced magnetic resonance imaging in the detection of cerebral metastases. Br J Radiol. 1990;63:712-715.
5. Chappell PM, Pelc NJ, Foo TK, et al. Comparison of lesion enhancement on spin-echo and gradient-echo images. AJNR Am J Neuroradiol. 1994;15:37-44.
6. Rand S, Maravilla KR, Schmiedl U. Lesion enhancement in radio-frequency spoiled gradient-echo imaging: theory, experimental evaluation, and clinical implications. AJNR Am J Neuroradiol. 1994;15:27-35.
7. Mugler JP 3rd, Brookeman JR. Theoretical analysis of gadopentetate dimeglumine enhancement in T1-weighted imaging of the brain: comparison of two-dimensional spin-echo and three-dimensional gradient-echo sequences. J Magn Reson Imaging. 1993;3:761-769.
8. Elster AD. How much contrast is enough? Dependence of enhancement on field strength and MR pulse sequence. Eur Radiol. 1997;suppl 5:S276-S280.
9. Pui MH, Fok ECM. MR imaging of the brain: comparison of gradient-echo and spine-echo pulse sequences. AJR Am J Roentgenol. 1995;165:959-962.
10. Mirowitz SA. Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging. Radiology. 1992;185:529-534.
11. Li D, Haacke EM, Tarr RW, et al. Magnetic resonance imaging of the brain with gadopentetate dimeglumine-DTPA: comparison of T1-weighted spin-echo and 3D gradient-echo sequences. J Magn Reson Imaging. 1996;6:415-424.
12. Patrons N, Bulakbasi N, Stratakis CA, et al. Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors. J Clin Endocrinol Metab. 2003;88:1565-1569.
13. Nobauer-Huhmann I-M, Ba-Ssalamah A, Mlynarik V, et al. Magnetic resonance imaging contrast enhancement of brain tumors at 3 Tesla versus 1.5 Tesla. Invest Radiol. 2002;3:114-119.
14. Ba-Ssalamah A, Nobauer-Huhmann IM, Pinker K, et al. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol. 2003;38:415-422.
15. Schorner W, Laniado M, Niendorf HP, et al. Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA. AJNR Am J Neuroradiol. 1986;7:1013-1020.
16. Yuh WTC, Tali ET, Nguyen HD, et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol. 1995;16:378-380.
17. Akeson P, Vikhoff B, Stahlberg F, et al. Brain lesion contrast in MR imaging. Dependence on field strength and concentration of gadodiamide injection in patients and phantoms. Acta Radiol. 1997;38:14-18.
18. Trattnig S, Pinker K, Ba-Ssalamah A, et al. The optimal use of contrast agents at high field MRI. Eur Radiol. 2006;16:1280-1287.
19. Wolff S, Balaban RS. Magnetization transfer imaging: Practical aspects and clinical applications. Radiology. 1994;192:593-599.
20. Duvvuri U, Roberts DA, Leigh JS, et al. Magnetization transfer imaging of the brain: a quantitative comparison of results obtained at 1.5T and 4.0T. J Magn Reson Imaging. 1999;10:527-532.
21. Fishbach F, Bruhn H, Pech M, et al. Efficacy of contrast medium use for neuroimaging at 3.0T. J Comput Assist Tomogr. 2005;29:499-505.